Zoetis Inc. Stock Underperforms Thursday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.Zoetis Inc. (ZTS) shares fell 2.16% to $75.02 on Thursday, underperforming the broader market as the S&P 500 and Dow Jones declined. This drop ended a two-day winning streak, with ZTS trading significantly below its 52-week high of $160.48. While competitors Merck & Co. and IDEXX Laboratories also saw declines, Zoetis's trading volume remained notably lower than its 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Zoetis Inc. (ZTS) shed 2.16% to $75.02 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.87% to 7,641.16 and Dow Jones Industrial Average falling 1.32% to 52,759.21.
The stock's fall snapped a two-day winning streak.
Zoetis Inc. closed 53.25% short of its 52-week high of $160.48, which the company reached on August 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Merck & Co. Inc. (MRK) fell 2.11% to $148.99 and IDEXX Laboratories Inc. (IDXX) fell 2.91% to $545.86.
Trading volume (3.9 M) remained 2.9 million below its 50-day average volume of 6.8 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 20, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-20-26 1657ET